AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Harel Insurance Investments & Finacial Services Ltd.

Regulatory Filings Dec 15, 2025

6832_rns_2025-12-15_3e725b80-5479-43fb-ab91-a5df0cf3edb5.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD

Registration Number: 520033986

To:

  • Israel Securities Authority
  • Tel Aviv Stock Exchange Ltd.

Form T121 (Public)

Filed in MAGNA: 15/12/2025 Reference: 2025-01-099807

Immediate Report for General Material Information

Explanation: Do not use this form when a customized form for the reported event exists.

This reporting form is intended for material disclosures for which there is no suitable designated form.

Results of an offering should be reported in form T20 and not in this form.

Reporting on BONDS rating or corporation rating must be submitted using form T125.

Nature of the event

_________, _________, _________.

Immediate report regarding application for withdrawal from a request to approve a class action - Harel Insurance

Reference numbers of previous related reports:

Report

Harel Insurance Investments & Financial Services Ltd. (the "Company") is pleased to report as follows:

This is an unofficial AI generated translation of the official Hebrew version and has no binding force. The only binding version is the official Hebrew version. For more information, please review the legal disclaimer.

As detailed in Note 12a(32) to the Company's financial statements as of September 30, 2025, published on November 25, 2025 (Reference: 2025-01-091342), and following the immediate report dated September 20, 2023 (Reference: 2023-01-088240):

In September 2023, a claim and a request to approve it as a class action were filed with the Regional Labor Court in Tel Aviv (the "Court") against the subsidiary, HAREL INSURANCE COMPANY LTD., and against Clalit Health Services (together: the "defendants"), on the grounds that the defendants tend to charge a parent for long-term care insurance for their child who reached the age of 19, supposedly, without explicit approval or consent prior to the start of the payment, and without notice, warning and/or information as required by law.

On December 15, 2025, the Court was submitted an application for the petitioners to withdraw from the approval request, within which the Court is requested to approve the withdrawal and order the dismissal of the individual claim of the petitioners.

The withdrawal request is subject to Court approval.

File attached:

The company is not a shell company as defined in the stock exchange rules.

The date the corporation first became aware of the event:

15/12/2025 at 14:15

Details of the authorized signatories for the corporation:

# Signatory Name Position
1 Gilad Shapira Company Legal Advisor

Explanation: According to Regulation 5 of the Periodic and Immediate Reports Regulations (1970), a report submitted according to these regulations shall be signed by the persons authorized to sign on behalf of the corporation. The staff position on the subject can be found on the Authority website: Click here.

The corporation's securities are listed for trading on the Tel Aviv Stock Exchange

Short Name: Harel Investments

Address: Aba Hillel 3, Ramat Gan 5211802

Phone: 03-7547090, 03-7547111; Fax: 03-7547100

Email: [email protected]

Company website: www.harel-group.co.il

Previous names of reporting entity:

Harel Insurance Investments and Finance Ltd., Harel Investments Insurance and Finance Ltd., Harel Insurance Investments Ltd., Harel Hamishmar Investments Ltd.

Electronic signatory name: Shapira Dov Gilad

Position: Legal Counsel

Employer:

Address: Aba Hillel 3, Ramat Gan 5211802

Phone: 03-7547090

Fax:

Email: [email protected]

Date of form structure last update: 06/08/2024

No images were included in the original document.

Talk to a Data Expert

Have a question? We'll get back to you promptly.